BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Shanghai Ark Biopharmaceutical Advances First In Human Trial Of Long Acting Influenza Therapy AK0406

Shanghai Ark Biopharmaceutical Co., Ltd. announced that the first cohort of healthy volunteers has been dosed in a phase I clinical trial of AK0406, a nove...

April 13, 2026 | News

NovogeneAIT Genomics Appointed To Advance PRECISE SG100K Proteomics Study In Singapore

NovogeneAIT Genomics announces its appointment as the designated service provider for the PRECISE-SG100K proteomics project. In this role, NovogeneAIT...

April 13, 2026 | News

Miracell Secures U.S. FDA Clearance For SMART M Cell System Advancing Regenerative Therapies

Blood- and bone marrow-based efficient growth factors extraction system demonstrates substantial equivalence and high cell viability Miracell, a...

April 13, 2026 | News

TriNetX Acquires Zetta Genomics Assets To Strengthen Multiomic Data Capabilities

TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient c...

April 09, 2026 | News

Everest Medicines To Acquire Hasten Biopharmaceuticals Singapore Unit In USD 250 Million Deal

Accelerates Asia Pacific expansion by acquiring a ready-built regional commercial platform with 14 marketed chronic disease products Aggregate considera...

April 09, 2026 | News

ATLATL And Daiichi Sankyo Partner To Advance APAC Driven Biopharma Innovation

ATLATL Innovation Center (hereinafter referred to as "ATLATL"), a global innovation platform for life science research and development, announced an agreem...

April 09, 2026 | News

Alar Pharmaceuticals Reports Positive Phase 1 Results For ALA 3000 In Treatment Resistant Depression

By reducing dissociation and sedation risk, ALA-3000 may eliminate the ≥2-hour post-dose monitoring requirement, reducing clinic operating costs, impr...

April 08, 2026 | News

Toshiba Corporation Advances Quantum Inspired Computing With 100 Fold Faster Optimisation Algorithm

Toshiba Corporation has developed a breakthrough algorithm that dramatically boosts the performance of the Simulated Bifurcation Machine (SBM), its proprie...

April 08, 2026 | News

Amgen Reports Strong Phase 3 Results For Subcutaneous TEPEZZA In Thyroid Eye Disease

Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful R...

April 08, 2026 | News

IDEAYA Biosciences Advances IDE574 Into Phase 1 As First Patient Enrolled For KAT6 And KAT7 Dual Inhibitor

Potential first-in-class and selective equipotent dual inhibitor of KAT6/7 with single-digit to low teens nano-molar cellular potency...

April 07, 2026 | News

Neurocrine Biosciences To Acquire Soleno Therapeutics For $2.9 Billion To Strengthen Rare Disease Portfolio

VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and...

April 07, 2026 | News

CellCarta And Pillar Biosciences Partner To Accelerate NGS Tumor Profiling For Biomarker Driven Oncology Trials

CellCarta, a global provider of precision medicine laboratory services for drug development, and Pillar Biosciences, a leader in NGS-based oncology molecul...

April 03, 2026 | News

Thermo Fisher Scientific Launches Gibco CHOvantage GS Cell Line Development Kit To Accelerate Biologics Development

Gibco CHOvantage GS Cell Line Development Kit delivers high productivity, streamlined timelines and royalty-free, clinical-stage licensing options to suppo...

April 02, 2026 | News

Gan And Lee Pharmaceuticals Reports Phase 3 Success For Once Weekly Insulin GZR4

Gan & Lee Pharmaceuticals announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 In...

April 02, 2026 | News

Stay Connected